Marksans Pharma Ltd

BSE : MARKSANS14 Feb 2025
Pharmaceuticals
-18.90 (-7.58%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Marksans Pharma Ltd
Marksans Pharma Ltd
Pharmaceuticals
BSE : MARKSANS14 Feb 2025
-18.90 (-7.58%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Marksans Pharma Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
45.76%
Upper Circuit
Lower Circuit
P/E TTM
56.94
P/B Ratio
8.10
Traded Value(Cr)
0.00
EPS TTM
4.05
Book value
Dividend
0.26%

Invest in Marksans Pharma Ltd at ZERO Brokerage for 30 days

Price Performance

-15.52 %
1 Wk
-10.59 %
1 M
-24.97 %
3 M
45.76 %
1 Y
-24.32 %
YTD

Traded Volume Movement

Technical Details

Support 3
198
Support 2
213
Support 1
222
Pivot Point :
237
Resistance 1
246
Resistance 2
261
Resistance 3
270

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Marksans Pharma Ltd
₹230.60(-18.90/-7.58%)
230.60-18.9010,449.9645.7656.948.10
Astrazeneca Pharma India Ltd
₹7,096.35(-314.25/-4.24%)
7,096.35-314.2517,740.8832.10105.8426.11
Bliss GVS Pharma Ltd
₹132.25(-5.05/-3.68%)
132.25-5.051,393.5211.6017.181.36
Amrutanjan Health Care Ltd
₹612.45(-25.00/-3.92%)
612.45-25.001,770.63-4.9135.905.95
Abbott India Ltd
₹27,859.05(-511.85/-1.80%)
27,859.05-511.8559,200.48-4.9244.3616.81
Ambalal Sarabhai Enterprises Ltd
₹48.41(-0.97/-1.96%)
48.41-0.97370.98-18.4142.108.23

About Marksans Pharma Ltd

Marksans Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 10449.96 crores. It has reported a sales of Rs. 311.87 crores and a net profit of Rs. 55.46 crores for the quarter ended December 2018. The company management includes Mark Saldanha, Mark Saldanha,Harshavardhan Panigrahi,Seetharama Raju Buddharaju,Sandra Saldanha,Digant Mahesh Parikh,Varddhman Vikramaditya Jain,Abhinna Sundar Mohanty,Sunny Sharma,Shailaja Vardhan (Marksans Pharma Ltd) among others.
Chairman
Mark Saldanha
Registered office
11th Flr GRANDEUR Oshiwara,Veera Desai Extn Rd Andheri(W),Mumbai,Maharashtra,400053
FAX :91-22-40012011
Background
Incorporation Year1992
Face Value₹1
Market Lot1

Latest News

Trump, Tariffs & Trades: Sensex ends in red for 8th straight day

India's equity indices fell for the eighth straight day, the longest losing streak in two years, due to concerns over Donald Trump's trade tariff proposals, with Nifty and Sensex declining 0.44% and 0.26% respectively. Analysts believe the market is oversold and a bounce back may depend on a slowdown in foreign fund selling.
15 Feb 2025 | 10:55 AM

Trump, Tariffs & Trades: Sensex ends in red for 8th straight day

India's equity indices fell for the eighth straight day, the longest losing streak in two years, due to concerns over Donald Trump's trade tariff proposals, with Nifty and Sensex declining 0.44% and 0.26% respectively. Analysts believe the market is oversold and a bounce back may depend on a slowdown in foreign fund selling.
15 Feb 2025 | 10:55 AM

Rategain Travel Technologies Q3 Results 2025 on 15 Feb, 2025

Rategain Travel Technologies Q3 Results 2025:Rategain Travel Technologies declared their Q3 results on 14 Feb, 2025, reporting a significant rise in profitability. The company’s profit surged by 39.88% year-on-year, reaching ₹56.54 crore, while revenue increased by 10.59% to ₹278.71 crore. Compared to the previous quarter, Rategain’s revenue grew by 0.52%, with profit rising by 8.29%.
15 Feb 2025 | 12:16 PM

Aditya Birla Fashion & Retail Q3 Results 2025 on 15 Feb, 2025

Q3 Results 2025: Aditya Birla Fashion & Retail declared their Q3 results on 14 Feb, 2025. The topline increased by 3.31% & the loss decreased by 34.11% YoY. Loss at  ₹51.31 crore and revenue at  ₹4304.69 crore. As compared to the previous quarter, the revenue grew by 18.14% and the loss decreased by 72.4%.
15 Feb 2025 | 12:01 PM

Swan Energy Q3 Results 2025 on 15 Feb, 2025: profit rise by 406.31% YOY

Swan Energy declared their Q3 results on 14 Feb, 2025, showcasing impressive financial growth. The topline increased by 19.89% year-on-year (YoY) while the profit skyrocketed by an astonishing 406.31% YoY, standing at ₹582.81 crore with total revenue reaching ₹1908.19 crore. In comparison to the previous quarter, the revenue grew significantly by 84.87%.
15 Feb 2025 | 11:57 AM

How to buy Marksans Pharma Ltd shares on nse?

To buy Marksans Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Marksans Pharma Ltd share price today?

The Marksans Pharma Ltd shares price on nse is Rs.230.6 today.

What is the market cap of Marksans Pharma Ltd shares on BSE ?

The company has a market capitalization of Rs.10449.96Cr

What is the PE & PB ratio of Marksans Pharma Ltd shares ?

PE is 56.94 and PB is 8.1

What is the 52 Week High and Low of Marksans Pharma Ltd shares?

Marksans Pharma Ltd stock price high: Rs.358.5 Marksans Pharma Ltd stock price low: Rs.126.05
Click here to see your activities